6 курс / Кардиология / Ишемическая_болезнь_сердца,_особенности_клинического_течения_в_условиях

Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). // JAMA. – 2001. – V.285. – P. 2486–2497.

150.Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. / E. Goodman, L.M. Dolan, J.A. Morrison et al. // Circulation. – 2005. – V.111. – P.1970 –1977.

151.Factor analysis of the metabolic syndrome among elderly Koreans–the South–west Seoul Study/ K.M. Choi, J. Lee J., K.B. Kim et al. // Diabet Med. –2003. – Feb. –V. 20, Suppl. 2. – P. 99–104.

152.Fatty liver and the metabolic syndrome among Shanghai adults. / J.G. Fan, J. Zhu, X.J. Li et al. // J. Gastroenterol Hepatol. – 2005. – V.20. – P.1825–1832.

153.Features of metabolic syndrome in non–diabetic Italians and Brazilians: a discriminant analysis. / M.L. Leite, A.Nicolosi, J.O.Firmo, et al. // Int. J. Clin. Pract. – 2007. – V.

61.– P.32–38.

154.Fontbonne, A. The Insulin resistance Syndrome and the Paris Prospective Study / A. Fontbonne, A. Charli // Cardiovascular. Risk. Factors. – 1993. –V. 3. – P. 36–43.

155.For the Study of Health Assessment and Risk in Ethnic Groups: Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Investigators. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. / S.S. Anand, Q. Yi, H. Gerstein et al. // Circulation. – 2003. – V. 108. – P.420–425.

156.Ford, E.S. A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions / E.S. Ford, W.H. Giles // Diabetes Care. – 2003. – V.26. – P. 575–581.

157.Ford, E.S. Increasing prevalence of the metabolic syndrome among U.S. Adults. / E.S. Ford, W.H. Giles, A.H. Mokdad // Diabetes Care. – 2004. – V.27. – P.2444 –2449.

158.Ford, E.S. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey / E.S. Ford, W.H. Giles, W.H. Dietz // JAMA. – 2002. – V. 287. – P. 356–359.

159.Ford, E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. / E.S. Ford // Diabetes Care. – 2005. – V. 28, N11.

– P. 2745 – 2749.

160.Galassi, A. Metabolic syndrome and risk of cardiovascular disease: a meta–analysis. / A. Galassi, K. Reynolds J. He // Am. J. Med. – 2006. – V.119. – P. 812–819.

161.Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program–Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects / C. Lorenzo, M. Serrano–Rios, M.T. Martinez– Larrad et al. // Diabetes Care. – 2006. – V.29. – P.685– 691.

162.Gillum, R. Body fat distribution, obesity, overweight and stroke incidence in women and men: the NHANES I Epidemic Follow–up Study / R. Gillum, M. Mussolino, J. Madans // Int. J. Obes. Relat. Metab. Disord. – 2001. – V. 25. – P. 628–638.

163.Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 / S. Wild, G. Roglic, A. Green et al. // Diabetes Care. – 2004. – V.27, N5. – P.1047–1053.

164.Glucose tolerance and insulin–resistance syndrome among St. Lawrence Island Eskimos / C.D. Schraer, S.O. Ebbesson, A. Adler et al. // Int. J. Circumpolar. Health. – 1998. – V.57, Suppl 1. – P.348–354.

165.Grundy, S.M. Metabolic syndrome pandemic / S.M. Grundy // Arterioscler. Thromb. Vasc. Biol. – 2008. – V.28. – P.629–636.

166.Haffner, S. Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects. / S.M. Haffner, L. Mykkanen, M. Stem // Diabetologia. – 1993. – V.42. – P.1297–1302.

~221 ~

167.Haller, H. Epidemiology and associated risk factors of hyperlipoproteinemia / H. Haller

//Z. Gesamte. Inn. Med. – 1977. – V.32. – P.124–128.

168.Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations/ G. Assmann, R. Guerra, G. Fox et al. // Am. J. Cardiol. – 2007. – V.99. – P.541–548.

169.Harmonizing the Metabolic syndrome / K.G. Alberti, R.N. Eckel, S.M. Grundy at al. //Circulation. – 2009. V. 120. – P. 1640–1645.

170.Harmonizing the metabolic syndrome: a joint interim statement of the IDF, NHLBI, AHA, WHF, IAS, IASO // Circulation. – 2009. – V.120, N16. – P. 1640–1645.

171.Hasnulin, V.I. Geophysical perturbations as the main cause of Northern human stress / V.I. Hasnulin // Alaska Medcine, Supplement. – 2007. – V. 49, N2. –P. 237–244.

172.Henefeld, M. Das metabolische Syndrome. Deutsch / M. Henefeld, W. Leonhardt // Ges. Wes. – 1980. – V. 36.–P. 545 – 551.

173.High prevalence of metabolic syndrome in Hong Kong Chinese–comparison of three diagnostic criteria. / G.T. Ko, C.S. Cockram, C.C. Chow et al. //Diabetes Res. Clin. Pract. – 2005. – V.69. – P.160–168.

174.Himsworth, H.P. Diabetes mellitus: a differentiation into insulinsensitive and insulin– insensitive types / H.P. Himsworth // Lancet. – 1936. – V.1. – P. 127–130.

175.Hossain, P. Obesity and diabetes in the developing world–a growing challenge. / P. Hossain, B. Kawar, M. Nahas // N. Engl. J. Med. – 2007. – V.356. – P.213–215.

176.Hwang L.C. Prevalence of obesity and metabolic syndrome in Taiwan. / L.C. Hwang, C.H. Bai, C.J. Chen // J. Formos. Med. Assoc. – 2006. – V.105. – P.626–635.

177.Hyperinsulinemia, insulin resistance and hyperglycemia: contributing factors in pathogenesis of hypertension and atherosclerosis / J.R. Sowers, P.R. Standley, J.L. Ram et al. // Am. J. Hypertens. – 1993. –V. 6. – P. S260–S270.

178.Hyperinsulinemia: a link between hypertension obesity and glucose intolerance / M. Modan, H. Halkin, S. Almog et al. // J. Clin. Invest. – 1985. – V. 75. – P. 809 – 817.

179.Hyperinsulinemia: the missing link among oxidative stress and age–related diseases? / F.S. Facchini, N.W. Hua, G.M. Reaven et al. // Free Rad. Biol. Med. – 2000. – V. 29. – P. 1302–1306.

180.Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study / G. Mancia, G. Parati, C. Borghi et al. // J. Hypertens. – 2006. – V.24. – P.837–843.

181.Impact of Insulin Resistance on Risk of Type 2 Diabetes and Cardiovascular Disease in People with Metabolic Syndrome / J.B. Meigs, M.K. Rutter, L.M. Sullivan et al. // Diabetes Care. – 2007. – V.30. – P.1219–1225.

182.Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study / D.B. Panagiotakos, C. Pitsavos, C. Chrysohoou et al.

//Am. Heart. J. – 2004. – V.147. – P.106–112.

183.Impaired fasting glucose and the metabolic syndrome in an indigenous Siberian population / J.J. Snodgrass, W.R. Leonard, L.A. Tarskaia et al. // Int. J. Circumpolar. Health. – 2010. – V. 69. – N 1. – P.87–98.

184.Indigenous health in the Arctic: an overview of the circumpolar Inuit population. / P. Bjerregaard, T.K. Young, E. Dewailly et al. //Scand. J. Public. Health. – 2004. – V.32, N5. – P.390–395.

185.Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. / H.J. Chen, C.H. Bai, W.T. Yen et al. // Stroke. – 2006. – V.37. – P.1060–1064.

186.Insulin resistance in essential hypertension / E. Ferrannini, G. Buzzigoli, R. Bonadonna et al. // N. Engl. J. Med. – 1987. – V. 317. – P. З50 –357.

~222 ~

187.Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study / H.E. Resnick, K. Jones, G. Ruotolo et al. // Diabetes Care. – 2003. – V.26. – P.861–867.

188.Insulin Sensitivity and the Risk of Incident Hypertension: Insights from the Insulin Resistance Atherosclerosis Study / D.C. Goff Jr., D.J. Zaccaro, S.M. Haffner et al. // Diabetes Care. – 2003. – 26 (3). – 805–809.

189.Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population/ M.J. Albrink, R.M. Krauss, F.T. Lindgrem at al. //Lipids. – 1980. - V.15. – P.668–676.

190.Is insulin the link between hypertension and obesity? / A.R. Christlieb, A.S. Krolewski, J.H. Warram et al. // Hypertension. – 1985. – V.7, N6. – Pt 2. – P.54–57.

191.Jarrett, R. In defence of insulin: a critique of Syndrom X / R. Jarrett // Lancet. – 1992. –

V.340. – P. 469–483.

192.Jorgensen, M.E. Cardiovascular diseases, diabetes and obesity. In: Young TK, Bjerregaard P, editors. Health transitions in Arctic populations. / M.E. Jorgensen, T.K. Young // Toronto: University of Toronto Press. – 2008. – P. 291–307.

193.Jorgensen, M.E. The metabolic syndrome – is one global definition possible? / M.E. Jorgensen, K. Borch–Johnsen // Diabet. Med. – 2004. – V.21, N 10. – P.1064–1065.

194.Kannel, W.B. Meaning of dowered trend in cardiovascular mortality / W.B. Kannel // JAMA. – 1982. –V. 247. – P. 877–880.

195.Kannel, W.B. The coronary profile: 12–year follow up in the Framinghram Study / W.B. Kannel, W.P. Castelli, M.P. Mc Namara // J. Occup. Med. – 1967. –V. 9. – P. 611–619.

196.Kaplan, N.M. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia, and hypertension / N.M. Kaplan // Arch. Int. Med. – 1989. – V. 149. – P. 1514–1520.

197.Karam, J.H. Type 2 diabetes and syndrome X. Pathogenesis and glycemic management. Review / J.H. Karam // Endocrinology & metabolism clinics of North America. – 1992. – V. 21, N2. – P. 329–350.

198.Khoury, S. The Patient with Syndrome X / S. Khoury, I. Khaled, J. Sowers // The ABCs of Antihypertensive Therapy. New York. – 1994. –V. 2. – P. 220.

199.Klein, B.E.K. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. / B.E.K. Klein, R. Klein, K.E. Lee // Diabetes Care. – 2002. – V.25. – P.1790–1794.

200.Kozlov, A.I. Indigenous peoplesof northern Russia: anthropology and health. / A.I. Kozlov, G. Vershubsky, M. Kozlova //Circumpolar Health Supplements. – 2007. – V.1.

– P.1–183.

201.Kozlov, A.I. Stress under modernization in Indigenous populations of Siberia. / A.I. Kozlov, G. Vershubsky, M. Kozlova //Int. J. Circumpolar. Health. – 2003. – V.62. – N10. – P.158–166.

202.Kue Young, Т. Factor analysis of ethnic in three Canadian populations / T. Kue Young,

D.Chateau, M. Zhang // Am. J. Human. Biol. – 2002. – V.14. – P.649– 658.

203.Kylin, E. Studien uber das Hypertonie–Hyperglykamie–Hyperurikamie syndrom / E. Kylin // Zentralbl. Inn. Med. – 1923. – V.44. – P.105–127.

204.Laaka, H.M. The metabolic syndrome and total and cardiovascular disease mortality in middle– aged men / H.M. Laaka, D.E. Laaksonen, T.A. Lakka // JAMA. – 2002. – V.288. – P.2709–2716.

205.Laakso, M. How good a marker is insulin level for insulin resistance? / M. Laakso // Am. J. Epidemiol. – 1993. – V. 137. – P. 959–965.

206.Laakso, М. Insulin resistance syndrome in Finland. / M. Laakso, T. Ronema, L.

~223 ~

Mykkanen //Cardiovasc. Risk Fact. – 1993. – V.3. – P.44–53.

207.Landsberg, L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis / L. Landsberg // Q. J. Med. – 1986. – Dec. – V.61, N236. – P.1081–1090.

208.Lerario, D.D. Weight excess and abdominal fat in the metabolic syndrome among Japanese– Brazilians / D.D. Lerario, S.G. Gimeno, L.J. Franco // Rev. Saude. Publ. – 2002. – V.36. – P.4–11.

209.Lin, S.X. Prevalence of the metabolic syndrome among US middle–aged and older adults with and without diabetes–a preliminary analysis of the NHANES 1999¬2002 data / S.X. Lin, E.X. Pi–Sunyer // Ethn. Dis. – 2007. – V. 17. – P.174.

210.Lopes, H.F. Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic / H.F. Lopes, B.M. Egan // Arq. Bras. Cardiol. – V. 87, N 4. – P. 123–126.

211.Lucove, J.C. Association Between Adult and Childhood Socioeconomic Status and Prevalence of the Metabolic Syndrome in African Americans: The Pitt County Study / J.C. Lucove, J.C. Kaufman, S.A. James // American Journal of Public Health. – 2007. – V.97. – P. 234–236.

212.Lui, J. Syndrome X: prevalence in large population study / J. Lui, M. Trevisan, A. Menotti // NMCD. – 1997. –V. 7. – P. 70–76.

213.Magliano, D.J. How to best define the metabolic syndrome / D.J. Magliano, J.E. Shaw, P.Z. Zimmet // Ann. Med. – 2006. – V. 38, N1. – P. 34–41.

214.Mehnert, H. Hypertonie and Diabetes mellitus / H. Mehnert, H. Kuhlmann // Deutsch. Med. J. – 1968. – V. 19. – P. 567–571.

215.Meigs, J.B. Epidemiology of the metabolic syndrome / J.B. Meigs // Am. J. Manag. Care. – 2002. – V. 8, Suppl.11. – P. S283–S292.

216.Meigs, J.B. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors / J.B. Meigs // Amer. J. Epidemiology. – 2000. – V.

152.– P. 908–911.

217.Metabolic Syndrome and 10–Year Cardiovascular Disease Risk in the Hoorn Study / M. Dekker, C. Girman, T. Rhodes et al. // Circulation. – 2005. – V.112. – P.666–673.

218.Metabolic syndrome and cardiovascular disease in older people: the Cardiovascular Health Study / A.M. McNeill, R. Katz, C.J. Girman et al. //J. Am. Geriatr. Soc. – 2006.

– V. 54. – P.1317–1324.

219.Metabolic syndrome and coronary heart disease in South Asians, African–Caribbeans and white Europeans: a UK population–based cross–sectional study / T. Tillin, N. Forouhi, D.G. Johnston et al. // Diabetologia. –2005. – V.48. – P.649–656.

220.Metabolic syndrome and C–reactive protein in the general population (JMS Cohort Study) / S.I. Ishikawa, K. Kayaba, T. Gotoh et al. // Circ. Res. – 2007. – V. 27. – P. 26–

221.Metabolic syndrome and mortality in stable coronary heart disease: relation to gender / C. Kragelund, L. Kober, J. Faber et al. // Int. J. Cardiol. – 2007. – V.121. – P.62–67.

222.Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta–analysis of longitudinal studies. / A.S. Gami, B.J. Witt, D.E. Howard et al. //J. Am. Coll. Cardiol. – 2007. – V.49. – P.403–414.

223.Metabolic syndrome as a predictor of all–cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study / G. Bruno, F. Merletti, A. Biggeri et al. // Diabetes Care. – 2004. – V.27. – P. 2689–2694.

224.Metabolic syndrome in a metapopulation of Croatian island isolates / I. Kolcic, A.Vorko–Jovic, B. Salzer et al. // Croat. Med. J. – 2006. – V.47. – P.585–592.

~224 ~

225.Metabolic syndrome in a sub–Saharan African setting: central obesity may be the key determinant / L. Fezeu, B. Balkau, A.P. Kengne et al. // Atherosclerosis. – 2006. – V.193. – P.70–76.

226.Metabolic Syndrome in Childhood: Association With Birth Weight, Maternal Obesity, and Gestational Diabetes Mellitus / Ch.M. Boney, A. Verma, R. Tucker et al. // Pediatrics. –2005. –V. 115, Suppl. 3. – Р. 290–296.

227.Metabolic syndrome in middle–aged Finnish population / M.G. Vanhala, T.K. Pitkajarvi, E.J. Kumpusalo et al. // J. Cardiovasc. Risk. – 1997. –V. 4. – P. 291–295.

228.Metabolic syndrome in normal–weight Iranian adults / F. Hadaegh, A. Zabetian, H. Harati et al. // Ann. Saudi. Med. – 2007. – V.27. – P.18–24.

229.Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni(PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis / G. Mancia, M. Bombelli, G. Corrao et al. // Hypertension. – 2007. – V.49. – P.40–47.

230.Metabolic syndrome in Yup’ik Eskimos: the Center for Alaska Native Health Research (CANHR) study/ B.B. Boyer, G.V. Mohatt, R. Plaetke et al. // Obesity. – 2007. – V.15, N11. – P.2535–2540.

231.Metabolic syndrome prevalence in a multicultural population in Auckland, New Zealand. / D. Gentles, P. Metcalf, L. Dyall et al. // N. Z. Med. J. – 2007. – V.120. – P. 2399.

232.Metabolic syndrome prevalence in Russia: Preliminary results of a cross–sectional population study / M. Mamedov, N. Suslonova, I. Lisenkova et al. // Diabet. Vasc. Dis. Res. – 2007. – V.4, N1. – P.46–47.

233.Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women. / M.A. Cabrera, O.C. Gebara, J. Diament et al. // Int. J. Cardiol. – 2007. – V.114. – P. 224–229.

234.Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all– cause mortality–results of prospective analysis for the Atherosclerosis Risk in Communities study / Y. Hong, X. Jin, J. Mo et al. // J. Intern. Med. – 2007. – V.262. – P.113–122.

235.Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels–a prospective and cross–sectional evaluation. / A. Onat, K. Ceyhan,

O.Basar et al. // Atherosclerosis. – 2002. – V.165. – P.285–292.

236.Metabolic syndrome: prevalence among American Indian and Alaska Native people living in the southwestern United States and in Alaska. / C. Schumacher, E.D. Ferucci, A.P. Lanier et al. // Metab. Syndr. Relat. Disord. – 2008. – V.6, N4. – P.267–273.

237.Microalbuminuria in hypertension is not a determinant of insulin resistance / I. Toft, K.H. Bonaa, J. Eikrem et al. // Kidney Int. – 2002. – V.61, N4. – P. 1445–1452.

238.Mishra, A. Obesity, and the Metabolic Syndrome in Developing Countries / A. Mishra,

L.Khurana // J. Clin. Endocrinol. Metab. – 2008. – V.93, Suppl. 1. – P. S9–S30.

239.National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report // Circulation. – 2002. – V.106. – P.3143–3421.

240.NCEP– defined metabolic syndrome, diabetes and prevalence of coronary heart disease among NHANES III participants age 50 years and older. / C.M. Alexander, P.B. Landsman, S.M. Teutsch et al. // Diabetes. – 2003. – V.52. – P.1210–1214.

241.Obesity and the metabolic syndrome in children and adolescents / R. Weiss, J. Dziura, T.S. Burgert et al. // N. Engl. J. Med. – 2004. – V.350, N23. – P. 2362 – 2374 .

~225 ~

242.Obesity in US Workers: The National Health Interview Survey, 1986 to 2002 / A.J. Caban, D.J. Lee, D.E. Fleming et al // Am. J. Public. Health. – 2005. – V.95. – P.1614– 1622.

243.Overweight and obesity in the United States: prevalence and trends, 1960–1994 / K.M. Flegal, M.D. Carroll, R.J. Kuczmarski et al. //Int. J. Obes. Relat. Metab. Disord. – 1998. – V.22. – P.39–47.

244.Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment / S.R. Daniels, D.K. Arnett, R.H. Eckel et al. // Circulation. – 2005. – V.111. – P.1999 –2012.

245.Pambianco, G. The Prediction of Major Outcomes of Type 1 Diabetes: A 12 year prospective evaluation of three separate definitions of the Metabolic Syndrome, and their components and estimated glucose disposal rate: The Pittsburgh Epidemiology of Diabetes Complications Study Experience / G. Pambianco, T. Costacou, T.J Orchard // Diabetes Care. – 2007. – V30. – P.1248–1254.

246.Panin, L.E. Human homeostasis in high–latitude environment / L.E. Panin // Alaska Medicine, supplement. – 2007. – V. 49, N2. – P. 25–26.

247.Phillips, G.B. Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction / G.B. Phillips // Proc. Natl. Acad. Sci. USA. – 1977. – V.74. – P.1729–1733.

248.Phillips, G.B. Sex hormones, risk factors and cardiovascular disease / G.B. Phillips // Am. J. Med. – 1978. – V.65. – P.7–11.

249.Physical activity volume as a key factor influencing obesity and metabolic syndrome prevalence in middle–aged men. Long–term prospective study / W. Drygas, A. Jegier, A. Bednarek–Gejo et al. // Przegl. Lek. – 2005. – V.62, Suppl 3. – P.8–13.

250.Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning / R. Weiss, S. Dufour, S. Taksali et al. // The Lancet. – 2003. –V. 362 – P. 951–957.

251.Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies / J.B. Meigs, P.W. Wilson, D.M. Nathan et al. // Diabetes. – 2003. – V.52. – P. 2160– 2167.

252.Prevalence and trends in obesity among US adults, 1999–2000 / K.M. Flegal, M.D. Carroll, C.L. Ogden et al. // JAMA. – 2002. – V.288. – P.1723–1727.

253.Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994 / S. Cook, M. Weitzman, P. Auinger et al. // Archives of Pediatrics and Adolescent Medicine. – 2003. –V. 157 – P. 821–827.

254.Prevalence of impaired glucose tolerance among children and adolescents with marked obesity / R. Sinha, G. Fisch, B. Теague et al. // N. Engl. J. Med. – 2002. – V.346. – P. 802–810.

255.Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. / P. Marques–Vidal, E. Mazoyer, V. Bongard et al. // Diab. Car. – 2002. – V.25. – P.1371–1377.

256.Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population. / Y. Feng, X. Hong, Z. Li et al. // Obesity (Silver Spring). – 2006. – V.14. – P.2089 –2098.

257.Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population / A. Csaszar, E. Kekes, T. Abel et al. //Blood Press. – 2006. – V.15. – P.101–106.

258.Prevalence of metabolic syndrome in an Indian urban population. / R. Gupta, P.C. Deedwania, A. Gupta et al. // Int. J. Cardiol. – 2004. – V.97. – P.257–261.

~226 ~

259.Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study / F. Azizi, P. Salehi, A. Etemadi et al. // Diabetes. Res. Clin. Pract. – 2003. – V. 61, N1. – P. 29 – 37.

260.Prevalence of overweight and obesity in the United States, 1999–2004 / C.L. Ogden, M.D. Carroll, L.R. Curtin et al. // JAMA. – 2006. – V.295. – P.1649 –1555.

261.Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions / M.E. Jorgensen, P. Bjerregaard, F. Gyntelberg, et al. // Diabet. Med. – 2004. – V.21. – P.1237–1242.

262.Prevalence of the metabolic syndrome among Turkish adults. / O. Kozan, A. Oguz, A. Abaci et al. // Eur. J. Clin. Nutr. – 2007. – V.61. – P. 548–553.

263.Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study / O. Sidorenkov, O. Nilssen, T. Brenn et al. // BMC Public Health. – 2010. – V.10. – P.23.

264.Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. / P. Ilanne– Parikka, J.G. Eriksson, J. Lindstrom et al. // Diabetes Care. – 2004. – V. 27. – P. 2135– 2140.

265.Prevalence of the metabolic syndrome and its relation to all–cause and cardiovascular mortality in nondiabetic European men and women. / G. Hu, Q. Qiao, J. Tuomilehto et al. //Arch. Intern. Med. – 2004. – V.164. – P.1066–1076.

266.Prevalence of the metabolic syndrome in middle–aged men and women / R. Villegas, I. Perry et al. // Diabetes. Care. – 2003. – V.26. – P.3198–3199.

267.Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

/V.G. Athyros, E.S. Ganotakis, M.S. Elisaf et al. // Int. J. Cardiol. – 2007. – V.117, N2.

– P.204–210.

268.Prospective an alyses of the insulin resistance syndrome (Syndrome X) / S.M. Haffner, R.A. Valdez, H.P. Hazuda et al. // Diabetes. – 1992. – V. 41. – P. 715 – 722.

269.Qiao, Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women / Q. Qiao // Diabetologia. – 2006. – V.49. – P.2837–2846.

270.Reaven, G.M. Banting Lecture: role of insulin resistance in human disease / G. M. Reaven, C. Hollenbeck, Y. Chen // Diabetes. – 1988. – V. 37. – P. 1595–1607.

271.Reaven, G.M. Role of insulin resistance in human disease: syndrom X / G.M. Reaven // In: 4th Int. Symp. on Multiple Risk Factors in Cardiovascul Dis. –Washington, 1997.

– P. 11.

272.Resnick, L.M. Ionic basis of hypertension, insulin resistance, vascular disease and related disorders / L.M. Resnick // Am. J. Hypertens. – 1993. –V. 6. – P. S123–S134.

273.Revised Adult Treatment Panel III Guidelines and Cardiovascular Disease Mortality in Men Attending a Preventive Medical Clinic / C.I. Ardern, P.T. Katzmarzyk, J. Janssen et al. //Circulation. – 2005. – V.112. – P. 1478–1485.

274.Rosenberg, B. Insulin resistance (metabolic) syndrome in children / B. Rosenberg, A. Moran, A.R. Sinaiko // Panminerva Med. – 2005. – V.47, N4. – P. 229 – 244.

275.Sarafidis, P.A. The metabolic syndrome: a glance at its history / P.A. Sarafidis, P.M. Nilsson //J. Hypertens. – 2006. – V.24. – P.621–626.

276.Singer, P. Diagnosis of primary hyperlipoproteinemias / P. Singer // Z. Gesamte. Inn. Med. – 1977. – V. 32. – P.129–133.

277.Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study / E.J. Brunner, M.G. Marmot, K. Nanchahal et al. //Diabetologia. – 1997. – V.40. – P.1341–1349.

278.Srinivasan, S.R. Changes in metabolic syndrome variables since childhood in

~227 ~

prehypertensive and hypertensive subjects: the Bogalusa Heart Study / S.R. Srinivasan,

L.Myers, G.S Berenson // Hypertension. – 2006. – V.48, N1. – P.33–39.

279.Steinberger, J. Obesity, insulin resistance, diabetes and cardiovascular risk in children. An American Heart Association Scientific Statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Counsil on Cardiovascular Disease in the Young) and Diabetes Committee (Council on Nutrition, Physical Activity and Metabolism) / J. Steinberger, S.R. Daniels // Circulation. – 2003. – V.107.

– P. 1448.

280.Stern, M.P. Diabetes and cardiovascular disease. The "common soil" hypotehesis. Review / M.P. Stern // Diabetes. –1995. –Apr. –V. 44,Suppl. 4. –P. 369–374.

281.Sy, R.G. Metabolic syndrome in Asia: time for action / R.G. Sy // Mes.S. Insights. – 2006. – V.9. – P.4–7.

282.Systolic Blood Pressure in Childhood Predicts Hypertension and Metabolic Syndrome Later in Life / S.S. Sun, G.D. Grave, R.M. Siervogel et al. // Pediatrics. – 2007. – V.119, N2. – P. 237–246.

283.Tan, S.E. Can We Apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians? / S.E. Tan, S. Ma, D. Wai // Diabetes Care. – 2004. – V.27. – P.1182–1186.

284.Tanaka, H. High prevalence of metabolic syndrome among men in Okinawa / H. Tanaka, T. Shimabukuro M. Shimabukuro // J. Atheroscler. Thromb. – 2005. – V.12. – P.284 –288.

285.Taskinen, M.R. Strategies for the diagnosis of metabolic syndrome / M.R. Taskinen // Current Opinion in Lipidology. – 1993. –V. 4. – P. 434–443

286.The continuing epidemics of obesity and diabetes in the United States. / A.H. Mokdad, B.A. Bowman, E.S. Ford et al. // JAMA. – 2001. – V.286. – P.1195–2000.

287.The emergence of obesity among Indigenous Siberians / J.J. Snodgrass, W.R. Leonard, M.V. Sorensen et al. // J. Physiol. Anthropol. – 2006. – V.25, N1. – P.75–84.

288.The influence of basal metabolic rate on blood pressure among Indigenous Siberians /

J.J.Snodgrass, W.R. Leonard, M.V. Sorensen et al. // Am. J. Phys. Anthropol. – 2008.

– V.137, N2. – P.145–155.

289.The metabolic syndrome among postmenopausal women in Ecuador. / L.A. Hidalgo, P.A. Chedraui, N. Morocho et al. //Gynecol. Endocrinol. – 2006. – V.22. – P.447– 454.

290.The metabolic syndrome and 11–year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) Study / A.M. McNeill, W. Rosamond, C.J. Girman et al. //Diabetes Care. – 2005. – V.28. – P.385–390.

291.The metabolic syndrome and total cardiovascular disease mortality in middle–aged men / H.M. Lakka, D.E. Laaksonen, T.A. Lakka et al. //JAMA. – 2002. – V.4. – N.288(21). – P. 2709–2716.

292.The metabolic syndrome as predictor of type 2 diabetes in San–Antonio Heart Study /

C.Lorenzo, M. Okoloise, K. Williams et al. // Diabetes Care. – 2003. – V.26. – P. 3153–3159.

293.The metabolic syndrome in Australia: prevalence using four definitions. / A.J. Cameron, D.J. Magliano, P.Z. Zimmet et al. //Diabetes Res. Clin. Pract. – 2007. – V.77. – P.471–478.

294.The metabolic syndrome in children and adolescents – an IDF consensus report / P. Zimmet, K.G. Alberti, F. Kaufman et al. // Pediatr. Diabetes. – 2007. – V.5. – P. 299– 306.

295.The metabolic syndrome in overweight Hispanic youth and role of insulin sensitivity. / M.L. Cruz, M.J. Weigensberg, T.T. Huang et al. //J. Clin. Endocr. Metab. – 2004. – V.89. – P. 108–113.

~228 ~

296.The metabolic syndrome in smokers. The D.E.S.I.R. study. / C. Geslain–Biquez, S. Vol, J. Tichet et al. //Diabetes Metab. – 2003. – V.29. – P.226–234.

297.The metabolic syndrome in Spanish migrants to Brazil: unexpected results / J.M. Pousada, M.M. Britto, T. Cruz et al. // Diabetes. Res. Clin. Pract. – 2006. – V.72. – P.75– 80.

298.The metabolic syndrome in the West Bank population: an urban–rural comparison / H.F., Abdul–Rahim, A. Husseini, E. Bjertness at al. // Diabetes Care. – 2001. – V.24. –

P.275–279.

299.The metabolic syndrome predicts cardiovascular mortality: a 13–year follow–up study in elderly non–diabetic Finns / J. Wang, S. Ruotsalainen, L. Moilanen et al. // Eur. Heart. J. – 2007. – V.28. – P.857–864.

300.The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study / I. Ferreira., R.M. Henry, J.W. Twisk et al. // Arch. Intern. Med. – 2005 – Apr. 25. –V. 165, Suppl. 8. – P. 875–882.

301.The Metabolic Syndrome. / Marc–Andre Cornier, D. Dabelea, T.L. Hernandez et al. // Endocr. Rev. – 2008. – V. 29. – P.777–822.

302.The metabolic syndrome. A prevalence and risk factors in the urban population of Ho Chi Minth City / N.T. Son Le, D. Kunii, N.T. Hung et al. // Diabetes. Res. Clin. Pract. – 2005. – V.67. – P.243–250.

303.The Metabolic Syndrome / M.A. Cornier, D. Dabelea, T.L. Hernandez et al. // Endocrine Reviews. – 2009. – V. 29, N7. – P.777–822.

304.The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988– 1994 / Y.W. Park, S. Zhu, L. Palaniappan et al. // Arch. Intern. Med. – 2003. – V.163. – P.427–436.

305.The National Cholesterol Education Program – Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes / C. Lorenzo, K. Williams, K.J. Hunt et al. // Diabetes Care. – 2007. – V.30, N1. – P.8–13.

306.The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study / N. Mattsson, T. Ronnemaa, M. Juonala et al. // J. Intern. Med. – 2007. – V.261. – P.159–69.

307.The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure // Arch. Intern. Med. – 1997. – V.157, N21. – P. 2413–2446.

308.Total energy expenditure in the Yakut (Sakha) of Siberia as measured by the doubly labeled water method / J.J. Snodgrass, W.R. Leonard, L.A. Tarskaia et al. // Am. J. Clin. Nutr. – 2006. – V.84, N4. – P.798–806.

309.Troiano, R.P. Overweight prevalence among youth in the United States: why so many different numbers? / R.P. Troiano, K.M. Flegal // Int. J. Obes. Relat. Metab. Disord. – 1999. – V. 23, Suppl 2. – P. S22 – S27 .

310.Tull, E.S. Metabolic syndrome among Caribbean–born persons living in the U.S. Virgin Islands / E.S. Tull, A. Thurland, R.E. LaPorte // Rev. Panam. Salud. Publica. – 2005. – V.186. – P.418–426.

311.Type 2 and other forms of diabetes in 0–30 year olds: a hospital based study in Leeds. /

R.Feltbower, P. McKinney., F. Campbell et al. // UK Archives of Disease in Childhood. – 2003. –V. 88. – P. 676–679.

312.Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in Mexican origin populations? The

~229 ~

Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study / C. Lorenzo, M. Serrano–Rios, M.T. Martinez–Larraz et al. //Diabetes Care. – 2001. – V.24. – P. 2059–2064.

313.Welborn, Т.А. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations / Т.А. Welborn, K. Wearne // Diabetes Care. –1991. –V.2. –P. 154– 160.

314.Woodford, F.P. Atherosclerosis X / F.P. Woodford, J. Davignon, A. Sniderman. - Exc. Medica, 1995. – 731 р.

315.World Health Organization Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva, Switzerland: World Health Organization, 1999.

– 174 p.

316.Young, Т.К. Epidemiology and control of chronio diseases in circumpolar Escimo / Inuit populations / Т.К. Young // Arct. Med. Res. – 1986. – V. 42. – P. 25 – 47.

317.Zabetian, A. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions / A. Zabetian, F. Hadaegh, F. Azizi // Diabetes Res. Clin. Pract. – 2007. – V.77. – P.251–257.

318.Zimmet, P. Preventing type 2 diabetes and the dysmetabolic syndrome in the real word: a realistic view / P. Zimmet, G. Shaw, G. Alberti // Deabetic medicine. – 2003. – V.20, N9. – P. 693–702.

~ 230 ~